The pilot run achieved approximately 99% reaction conversion, 90% isolated yield, and 535 grams of NCT at 99.6% pharma-grade purity. eXoZymes Inc. (NASDAQ:EXOZ) What makes this initial NCT pilot run ...
This pilot run is an important validation of our cell-free platform, demonstrating that it performs reliably at scale and delivers strong results in the hands of an external partner.” — Damien ...
LOS ANGELES, CA, UNITED STATES, March 18, 2026 /EINPresswire.com/ — Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-enhanced enzymes that ...
LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results